Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2026-08-21 | Reverse | 1:10 |
| 2024-05-21 | Reverse | 1:10 |
| 2022-11-25 | Reverse | 1:10 |
Scinai Immunotherapeutics Ltd., based in Jerusalem, develops and commercializes antibody-based therapies for infectious and autoimmune diseases, including COVID-19 NanoAbs, through collaborations with Max Planck and University Medical Center Götti...

Scinai Immunotherapeutics's Scinai BioServices provides boutique CDMO support from early research to cGMP manufacturing for biotech clients, driving major revenue growth.
| Icon | PRODUCT | FY2024 |
|---|---|---|
![]() | License | $100K |
Overall rating: C
| PEER | PRICE | |
|---|---|---|
INDP | $1.14 | COMPARE |
JSPR | $0.70 | COMPARE |
REVB | $1.05 | COMPARE |
ONCO | $0.61 | COMPARE |
ENVB | $1.37 | COMPARE |
SPRC | $6.58 | COMPARE |
SLXN | $0.36 | COMPARE |
PBM | $4.21 | COMPARE |